Showing results (41-50 of 171) with videos related to
Sort By:
Pageof 18
Current Oncology Reports|October 22, 2025
Genetically Modified Mouse Models for Sarcoma Research: A Comprehensive ReviewPiotr Remiszewski, Eryk Siedlecki, Marlena Wełniak-Kamińska, et al.Current Treatment Options in Oncology|May 29, 2024
What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?Paulina Chmiel, Piotr Rutkowski, Mateusz Spałek, et al.Current Signal Transduction Therapy|August 26, 2014
Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)Zofia F Bielecka, Anna M Czarnecka, Wojciech Solarek, et al.Current Signal Transduction Therapy|August 26, 2014
Metastasis-Initiating Cells in Renal CancerMohammed I Khan, Anna M Czarnecka, Renata Duchnowska, et al.Molecular Cancer|December 21, 2016
Choosing the right cell line for renal cell cancer researchKlaudia K Brodaczewska, Cezary Szczylik, Michal Fiedorowicz, et al.American Journal of Physiology. Renal Physiology|June 10, 2016
Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell lineMohammed I Khan, Konrad J Dębski, Michał Dabrowski, et al.BMC Cancer|May 17, 2011
Laryngeal embryonal rhabdomyosarcoma in an adult - a case presentation in the eyes of geneticists and cliniciansWojciech Kukwa, Piotr Wojtowicz, Beata Jagielska, et al.Medical Oncology (Northwood, London, England)|May 9, 2018
Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinomaPawel Chrom, Maciej Kawecki, Rafal Stec, et al.Journal of Applied Genetics|October 31, 2025
MicroRNA bioinformatics in precision oncology: an integrated pipeline from NGS to AI-based target discoveryMritunjoy Dey, Piotr Remiszewski, Jakub Piątkowski, et al.International Journal of Molecular Sciences|March 28, 2024
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in ChondrosarcomaPalina Skipar, Mritunjoy Dey, Jakub Piątkowski, et al.Pageof 18